Riskpilot← Back to searchSign inGet full accessMEDEST AS
ASActiveOrg 915880266President Harbitz' Gate 20D, 0259 OsloOther human health activities n.e.c. · NACE 8699Est. 20150 employees
Revenue 2024
NOK 1,8M
-12% vs 2023
EBITDA margin
-18.1%
-63% vs 2023
Equity ratio
42.2%
Financial strength
Net profit 2024
NOK -201K
+25% vs 2023
| Revenue | NOK 1,8M | -12% |
| EBITDA | NOK -331K | -63% |
| Net profit | NOK -201K | +25% |
| Total assets | NOK 819K | -33% |
| Equity | NOK 346K | -37% |
| Employees | 0 | — |
Legal name
MEDEST AS
Org number
915880266
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
14. september 2015
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Helsetjenester, delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
President Harbitz' Gate 20D, 0259 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 129 | 2 902 | 2 540 | 2 081 | 1 826 |
| Staff expenses | −0 | −0 | −10 | −0 | −7 |
| EBITDA | 621 | 438 | 60 | −203 | −331 |
| Depreciation & amort. | −162 | −188 | −192 | −193 | −56 |
| EBIT | 459 | 250 | −132 | −396 | −387 |
| Net financials | 35 | −0 | −2 | 52 | 135 |
| Profit before tax | 494 | 250 | −133 | −343 | −252 |
| Tax | 100 | 60 | −28 | −75 | −52 |
| Net profit | 394 | 190 | −106 | −268 | −201 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 556 | 1 878 | 1 635 | 1 215 | 819 |
| Equity | 731 | 920 | 815 | 546 | 346 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 826 | 958 | 820 | 669 | 473 |
| Total debt | 826 | 958 | 820 | 669 | 473 |
EBITDA margin
-18.1%
This company
15.8%
Market median
-215% vs market
20202024
Equity ratio
42.2%
This company
38.2%
Market median
+10% vs market
20202024
Return on equity
-58.0%
This company
18.4%
Market median
-415% vs market
20202024
Net profit margin
-11.0%
This company
8.1%
Market median
-236% vs market
20202024
Asset turnover
2.23×
This company
1.12×
Market median
+99% vs market
20202024
Debt / equity
1.37×
This company
0.62×
Market median
-121% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2015 | |
| Board of Directors | 2015 | |
| Chairman | 2015 | |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gregoire Carl Truedsson | Board of Directors | 0 companies |
| Veronique-Claude-Marie Truedsson | Board of Directors | 0 companies |
| Claes Stephan Truedsson | Chairman | 0 companies |